Please wait a minute...

中国现代手术学杂志  2018, Vol. 22 Issue (2): 133-136    DOI: 10.16260/j.cnki.1009-2188.2018.02.013
  临床论著 |
抽吸导管联合盐酸替罗非班在PCI治疗急性心肌梗塞中的临床疗效研究
罗蓉,朱新林,杨雯婷
解放军第163医院 湖南师范大学第二附属医院心血管内科, 长沙 410003
The Clinical Efficacy of the Thrombus Aspiration Catheter Combined with Tirofiban Hydrochloride in theInterventional Treatment of Acute Myocardial Infarction
LUO Rong, ZHU Xin-lin, YANG Wen-ting
Cardiology?Department,?No. 163?Central?Hospital?of?PLA,?The?Second?Affiliated?Hospital?of?Hunan?Normal?University,?Changsha?410003,?Hunan,?China
下载:  RICH HTML  PDF (193KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 目的 通过研究抽吸导管联合非肽类血小板表面糖蛋白GP Ⅱb/Ⅲa受体拮抗剂(盐酸替罗非班注射液)经皮冠状动脉介入术(percutaneous coronary intervention, PCI)治疗急性心肌梗塞的临床应用,评价其疗效。 方法 2012年1月至2017年10月,我科收治急性心肌梗塞拟行PCI的患者80例,随机分成2组,每组各40例。A组(抽吸导管联合盐酸替罗非班):通过导丝后直接给予盐酸替罗非班注入,送入抽吸导管行血栓抽吸后再置入支架。B组(常规肝素抗凝):通过导丝后直接给予球囊扩张,再根据病变情况置入支架。比较两组患者术中TIMI血流情况,术后肌酸激酶同工酶(CK-MB)、肌钙蛋白Ⅰ(TnⅠ)水平、ST段下降率,及术后30 d的主要心血管不良事件( MACE)等。 结果 A组35例行导管抽吸后置入支架,5例患者血栓抽吸后同时注入替罗非班血流恢复正常,轻度狭窄,未置入支架;40例患者中只有2例出现TIMI 0~Ⅱ级。B组中有10例病人球囊扩张或支架植入后出现TIMI血流0~Ⅱ级(P<0.05)。A组病人术后CK-MB、TnⅠ水平低于B组(P<0.05), ST段回落幅度大于B组 (P<0.05);A组患者恶性心律失常、心源性死亡、再发心肌梗死等并发症的总发生率低于B组(P<0.05)。 结论 在急性心肌梗塞急诊PCI术中,联合应用抽吸导管和盐酸替罗非班注射液可明显降低无复流发生率,明显减少MACE的发生,提高心肌灌注,并改善临床预后。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
罗蓉,朱新林,杨雯婷
关键词:  经皮冠状动脉介入术   抽吸导管   盐酸替罗非班    
Abstract: Objective To evaluate the clinical application of GPⅡb/ Ⅲa receptor antagonist (Tirofiban hydrochloride injection)combined with the thrombus aspiration catheter in the percutaneous coronary intervention(PCI) treatment for acute myocardial infarction (AMI). Methods From January 2012 to October 2018, 80 patients with AMI planned for PCI treatments in our department were randomly divided into 2 groups, with 40 cases in each. Group A received PCI following thrombus aspiration catheter insertion and tirofiban hydrochloride injection. Group B received PCI following heparin anti-coagulation. Results In group A, stents were implanted in 35 cases after catheter suction. 5 cases who were injected with tirofiban returned to normal blood flow with mild stenosis and had no stents inserted after thrombus aspiration. And only 2 cases appeared no reflow phenomenon. In group B, 10 cases appeared no reflow phenomenon(P<0.05) after balloon expansion or stent implantation. In group A, the levels of CK-MB and TnI were lower than that of the control group(P<0.05). The incidence of malignant arrhythmia, cardiac death and recurrent myocardial infarction in group A were lower than that of the control group (P<0.05). Conclusion In the course of emergency PCI operation, thrombus aspiration catheter combined with Tirofiban hydrochloride injection can obviously reduce the incidence of no reflow phenomenon, reduce the occurrence of MACE, increase the myocardial perfusion and improve the clinical prognosis.
Key words:  percutaneous coronary intervention     aspiration catheter    tirofiban hydrochloride
               出版日期:  2018-04-26      发布日期:  2018-08-14      期的出版日期:  2018-04-26
ZTFLH:  R541.4  
通讯作者:  朱新林,男,47岁,解放军第163医院 湖南师范大学第二附属医院心血管内科副主任医师。   
作者简介:  罗蓉,女,32岁,解放军第163医院 湖南师范大学第二附属医院心血管内科。
引用本文:    
罗蓉,朱新林,杨雯婷. 抽吸导管联合盐酸替罗非班在PCI治疗急性心肌梗塞中的临床疗效研究[J]. 中国现代手术学杂志, 2018, 22(2): 133-136.
LUO Rong. The Clinical Efficacy of the Thrombus Aspiration Catheter Combined with Tirofiban Hydrochloride in theInterventional Treatment of Acute Myocardial Infarction. Chinese Journal of Modern Operative Surgery, 2018, 22(2): 133-136.
链接本文:  
http://www.surgerychina.com/CN/10.16260/j.cnki.1009-2188.2018.02.013  或          http://www.surgerychina.com/CN/Y2018/V22/I2/133
[1] Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardialinfarction: the INFUSE-AMI randomized trial[J]. JAMA, 2012 ,307(17):1817-1826. doi: 10.1001/jama.2012.421.|[2] 中华心血管病委员会. 急性心肌梗塞诊断和治疗指南[J]. 中华心血管病杂志,2001,29(12):713-714.|[3] 赵树武, 张凯, 徐林东. 血栓抽吸联合经皮冠状动脉介入术治疗ST段抬高型心肌梗死的临床效果及安全性分析[J]. 实用心脑肺血管病杂志,2016,24(3):115-116.|[4] 朱红涛, 刘学庆, 丁晓军, 等. 急性ST段抬高型心肌梗死患者经抽吸导管冠脉内局部推注替罗非班的疗效研究[J]. 中国循证心血管医学杂志,2017,9(6):728-741.|[5] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志,2010,38(8):675-687.|[6] 中华医学会心血管病委员会, 中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南 2012(简本)[J]. 中华心血管病杂志,2012,40(4):271-277.|[7] 洪涛. 冠状动脉TIMI 血流分级[J]. 中国介入心脏病学杂志,2003,11 (3 ):154.|[8] 陈亭杰, 杨锋. PCI 患者术后即刻心肌血流储备分数和脑钠尿肽水平对患者预后的影响[J]. 中国心血管病研究,2016,14(1):42-44.|[9] 赵向利. 关于冠脉介入治疗术中无复流研究的进展[J]. 心血管康复医学杂志,2014,23(6):688-691.|[10] Kaul S.The "no reflow" phenomenon following acute myocardial infarction: mechanisms and treatmentoptions[J]. J Cardiol, 2014,64(2):77-85. doi: 10.1016/j.jjcc.2014.03.008.|[11] 刘如晨, 徐争鸣. Angiojet 血栓抽吸导管在急性ST段抬高型心肌梗死中的应用研究[J]. 中国全科医学, 2016,19(12):1472-1475.|[12] Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Eur Heart J, 2012,33(20):2569-2619. doi: 10.1093/eurheartj/ehs215.|[13] 朱新林. 替罗非班对急性心肌梗死患者急诊PCI术中TIMI血流的影响[J]. 中国现代手术学杂志, 2010,14(6):426-428.|[14] Hara M, Saikawa T, Tsunematsu Y, et al. Hara M, Saikawa T, Tsunematsu Y,et al.Predicting no-reflow based on angiographic features of lesions in patients with acute myocardialinfarction[J]. J Atheroscler Thromb, 2005,12(6):315-321.|[15] Candemir B, Kilickap M, Ozcan OU, et al. Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevationmyocardial infarction[J]. J Thromb Thrombolysis, 2012,34(1):65-72. doi: 10.1007/s11239-012-0685-y.|[16] 江宏飞, 王焱, 黄卫斌, 等. 抽吸导管在急性心肌梗塞患者急诊经皮冠脉介入治疗中的应用[J]. 心血管康复医学杂志,2010,19(1):68-70.|[17] 宗振方, 董平栓. 急性心肌梗死PCI术中慢血流或无复流现象的防治现状[J]. 河南科技大学学报医学版,2013,32(1):73-78.
No related articles found!
No Suggested Reading articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed